While AI offers remarkable efficiency, the pharmaceutical industry must address concerns about “black box” predictions – AI ...

CAMBRIDGE, MA / ACCESS Newswire / March 31, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Australian Therapeutic Goods Administration (TGA) has granted approval for mRESVIA® (mRNA-1345), ...

Researchers at the University of Cologne have found that mRNA-based COVID-19 vaccines have a lasting impact on the innate ...

Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted marketing authorization for mRESVIA (mRNA-1345), indicated for ...

Quantoom Biosciences and DIANT Pharma Inc. Collaborate to Enhance mRNA Supply Chain Efficiency Quantoom Biosciences and DIANT Pharma Inc. are proud to announce a strategic collaboration to advance the ...

A genetic mutation in horses that would typically halt protein production has become a molecular asset. Researchers at Johns ...

Werner held roles at Bristol Myers Squibb, AstraZeneca and Novartis before landing at Alltrna, where she works to develop tRNA-based treatments for a range of diseases.

Top FDA official Peter Marks was forced to resign as the director of the Center for Biologics Evaluation and Research.

How cardiac cell fates are specified during heart development remains elusive. This study identifies a level-dependent role ...